Susquehanna International Group, LLP Codiak Bio Sciences, Inc. Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.24 - $6.96 $27,345 - $84,967
-12,208 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$4.3 - $12.95 $8,961 - $26,987
-2,084 Reduced 14.58%
12,208 $77,000
Q4 2021

Feb 14, 2022
BUY
$10.0 - $16.78 $142,920 - $239,819
14,292 New
14,292 $159,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Codiak BioSciences, Inc.

CDAK Quotes by TradingView
  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email